Apr 2020 $14 M No. 7 $10 to $50 million 4
Intact Vascular, Inc.: Raise no. 7, Apr 2020 × Investors in this round 4 investors had bought by the notice of May 5, 2020: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $15 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $1,031,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bruce J. Shook · Executive Officer, Director Douglas G. Evans · Executive Officer, Director Joseph C. Griffin, III · Executive Officer Monica W. Klos · Executive Officer Peter G. Schneider · Executive Officer, Director Bruce J. Robertson · Director Dennis W. Wahr · Director Josh G. Makower · Director P. Sherrill Neff · Director Peter Justin Klein · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Bruce J. Shook, President, CEO. Source: SEC Form D, newest notice filed May 5, 2020. Read the notice at the SEC .
debt, options SEC May 2019 $5 M No. 6 $2 to $10 million 1
Intact Vascular, Inc.: Raise no. 6, May 2019 × Investors in this round 1 investor had bought by the notice of Jun 4, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $25 M offered; $20 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $5,100,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bruce J. Shook · Executive Officer, Director Howard C. Rosen · Executive Officer Joseph C. Griffin, III · Executive Officer Marc C. Penna · Executive Officer Michael C. Longo · Executive Officer Monica W. Klos · Executive Officer Stephen G. MacKinnon · Executive Officer Bruce G. Robertson · Director Dennis W. Wahr · Director Douglas G. Evans · Director Josh G. Makower · Director P. Sherrill Neff · Director Peter G. Schneider · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Bruce J. Shook, President, CEO. Source: SEC Form D, newest notice filed Jun 4, 2019. Read the notice at the SEC .
equity, options SEC Apr 2018 $10 M No. 5 $10 to $50 million 3
Intact Vascular, Inc.: Raise no. 5, Apr 2018 × Investors in this round 3 investors had bought by the notice of Apr 13, 2018: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $22 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $2,100,000 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bruce J. Shook · Executive Officer, Director Howard J. Rosen · Executive Officer Joseph C. Griffin, III · Executive Officer Marc C. Penna · Executive Officer Michael G. Longo · Executive Officer Monica G. Klos · Executive Officer Aaron J. Davidson · Director Dennis Sherrill Wahr · Director Douglas G. Evans · Director Justin J. Klein · Director P. Sherrill Neff · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Bruce J. Shook, President, CEO. Source: SEC Form D, newest notice filed Apr 13, 2018. Read the notice at the SEC .
equity, options SEC May 2015 $39 M No. 4 $10 to $50 million 8
Intact Vascular, Inc.: Raise no. 4, May 2015 × Investors in this round 8 investors had bought by the notice of Jan 17, 2017: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $39 M of $39 M offered
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $4,900,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bruce J. Shook · Executive Officer, Director Joseph C. Griffin, III · Executive Officer Marc C. Penna · Executive Officer Michael G. Longo · Executive Officer Monica G. Klos · Executive Officer Peter J. Schneider · Executive Officer, Director Aaron J. Davidson · Director Dennis Sherrill Wahr · Director Douglas G. Evans · Director Justin J. Klein · Director P. Sherrill Neff · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The amount does not include approximately $6.5 million in proceeds previously received by the company from the issuance and sale of convertible promissory notes that were converted into securities in connection with this offering.”Signed by Bruce J. Shook, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 17, 2017. Read the notice at the SEC .
equity SEC Mar 2015 $3 M No. 3 $2 to $10 million 15
Intact Vascular, Inc.: Raise no. 3, Mar 2015 × Investors in this round 15 investors had bought by the notice of Mar 19, 2015: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $6 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people $710,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bruce J. Shook · Executive Officer, Director Bryan A. Claseman · Executive Officer Douglas G. Evans · Executive Officer, Director Holly G. Harrity · Executive Officer Joseph C. Griffin · Executive Officer Marc G. Penna · Executive Officer Aaron D. Davidson · Director Dennis Sherrill Wahr · Director Katherine D. Crothall · Director P. Sherrill Neff · Director Peter J. Schneider · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Bruce J. Shook, President and CEO. Source: SEC Form D, newest notice filed Mar 19, 2015. Read the notice at the SEC .
debt, options SEC Dec 2013 $5 M No. 2 $2 to $10 million 5
Intact Vascular, Inc.: Raise no. 2, Dec 2013 × Investors in this round 5 investors had bought by the notice of Dec 20, 2013: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $9 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: Security to be Acquired Upon Conversion of Debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $761,250 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Carol A. Burns · Executive Officer, Director Douglas G. Evans · Executive Officer, Director Robert G. Giasolli · Executive Officer Aaron D. Davidson · Director Dennis Sherrill Wahr · Director Katherine D. Crothall · Director P. Sherrill Neff · Director Peter A. Schneider · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Carol A. Burns, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 20, 2013. Read the notice at the SEC .
equity, debt SEC Aug 2012 $11 M No. 1 $10 to $50 million 42
Intact Vascular, Inc.: Raise no. 1, Aug 2012 × Investors in this round 42 investors had bought by the notice of Aug 30, 2012: 42 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $19 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Carol A. Burns · Executive Officer, Director Robert D. Giasolli · Executive Officer Scott H. Kruas · Executive Officer Aaron D. Davidson · Director Dennis H. Wahr · Director Katherine D. Crothall · Director Peter A. Schneider · Director Wesley H. Kaupinen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes cash proceeds and proceeds of indebtedness of the Issuer converted in the offering”Signed by Carol A. Burns, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 30, 2012. Read the notice at the SEC .
equity SEC